Korea 2014 Outlook: Not Much Positive News On Pharma
This article was originally published in PharmAsia News
Executive Summary
Because of continuing pressure on drug prices for the country’s National Health Insurance and on illegal rebates, the outlook for the year ahead is not positive for both Korean pharma and multinational companies.